Evaluation of Adherence and Persistence Differences Between Adalimumab Citrate-Free and Citrate Formulations For Patients With Immune-Mediated Diseases in The United States
mediaposted on 2020-11-19, 17:35 authored by Martin Bergman, Pankaj Patel, Naijun Chen, Yonghua Jing, Christopher D. Saffore
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2020.